Gastroenterology Fellowship – Massachusetts General Hospital, Boston, MA
Hepatology Clinical Fellows
M.D. University of Hawaii John A. Burns School of Medicine.
Residency SUNY Upstate Medical University
Current interests include long term follow up of patients treated for Hepatitis C, Fontan associated liver disease and fatty liver disease in unique patient populations. I am also matriculating to the NIH-Duke Master's Program in Clinical Research.
M.D - Université de Montréal, Montreal, Canada
Internal Medicine Residency - Université de Montréal, Canada
Gastroenterology Fellowship - Université de Montréal, Canada
Recently, he was part of the liver unit at the Centre hospitalier de l’Université de Montréal (CHUM) before beginning his hepatology fellowship at the NIDDK.
During his stay at the LDB, he plans on taking part in clinical research trials focusing on novel pharmaceutical approaches for viral hepatitis and to pursue his interest in auto-immune liver disease as well as hepatic involvement in systemic diseases.
M.D – Universidad Dr. Jose Matias Delgado, El Salvador
Internal Medicine Residency - Bridgeport Hospital, Yale New Haven Health, Connecticut.
Recently, I completed my internal medicine residency at Bridgeport Hospital, Yale New Haven Health before beginning my hepatology fellowship at the NIDDK. During my stay at the LDB, I plan on taking part in clinical research trials focusing on the study of portal hypertension, non-cirrhotic portal hypertension and fatty liver disease Complications, diagnostics and treatment options.
M.D. – Ben-Gurion University of the Negev, Goldman Medical School, Beer-Sheva, Israel
Internal Medicine Residency – Soroka University Medical Center, Beer-Sheva, Israel
Gastroenterology Fellowship – Soroka University Medical Center, Beer-Sheva, Israel
Observing the results of decompensated liver diseases during my residency in internal medicine and my fellowship in gastroenterology have profoundly impacted my interest in hepatology. The introduction in recent years of novel pharmacological agents leading to improved treatment of liver diseases that were incurable just a few years ago, has demonstrated once again the importance of conducting meaningful studies that will influence the patients’ health and quality of life. For these reasons I am now participating in the Hepatology fellowship at the Liver Disease Branch of the NIH.
My current research interests include viral Hepatitis B and D, Non-Alcoholic Fatty Liver disease and Fontan Associated Liver Disease.